BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomas R, Weihua Z. Rethink of EGFR in Cancer With Its Kinase Independent Function on Board. Front Oncol 2019;9:800. [PMID: 31508364 DOI: 10.3389/fonc.2019.00800] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Janani B, Vijayakumar M, Priya K, Kim JH, Prabakaran DS, Shahid M, Al-ghamdi S, Alsaidan M, Othman Bahakim N, Hassan Abdelzaher M, Ramesh T. EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges. Vaccines 2022;10:499. [DOI: 10.3390/vaccines10040499] [Reference Citation Analysis]
2 Rinne SS, Orlova A, Tolmachev V. PET and SPECT Imaging of the EGFR Family (RTK Class I) in Oncology. Int J Mol Sci 2021;22:3663. [PMID: 33915894 DOI: 10.3390/ijms22073663] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Sharifi-noghabi H, Harjandi PA, Zolotareva O, Collins CC, Ester M. Out-of-distribution generalization from labelled and unlabelled gene expression data for drug response prediction. Nat Mach Intell 2021;3:962-72. [DOI: 10.1038/s42256-021-00408-w] [Reference Citation Analysis]
4 Peckys DB, Gaa D, de Jonge N. Quantification of EGFR-HER2 Heterodimers in HER2-Overexpressing Breast Cancer Cells Using Liquid-Phase Electron Microscopy. Cells 2021;10:3244. [PMID: 34831465 DOI: 10.3390/cells10113244] [Reference Citation Analysis]
5 Mohi El-deen EM, Anwar MM, Abd El-gwaad AA, Karam EA, El-ashrey MK, Kassab RR. Design and synthesis of some novel pyridothienopyrimidine derivatives and their biological evaluation as antimicrobial and anticancer agents targeting EGFR enzyme. Arabian Journal of Chemistry 2022;15:103751. [DOI: 10.1016/j.arabjc.2022.103751] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Luiz MT, Dutra JAP, Tofani LB, de Araújo JTC, Di Filippo LD, Marchetti JM, Chorilli M. Targeted Liposomes: A Nonviral Gene Delivery System for Cancer Therapy. Pharmaceutics 2022;14:821. [DOI: 10.3390/pharmaceutics14040821] [Reference Citation Analysis]
7 Paranthaman S, Goravinahalli Shivananjegowda M, Mahadev M, Moin A, Hagalavadi Nanjappa S, Nanjaiyah N, Chidambaram SB, Gowda DV. Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management. Pharmaceutics 2020;12:E1198. [PMID: 33321953 DOI: 10.3390/pharmaceutics12121198] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vayá I, Andreu I, Lence E, González-Bello C, Consuelo Cuquerella M, Navarrete-Miguel M, Roca-Sanjuán D, Miranda MA. Characterization of Locally Excited and Charge-Transfer States of the Anticancer Drug Lapatinib by Ultrafast Spectroscopy and Computational Studies. Chemistry 2020;26:15922-30. [PMID: 32585059 DOI: 10.1002/chem.202001336] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Nikas IP, Lee C, Song MJ, Kim B, Ryu HS. Biomarkers expression among paired serous ovarian cancer primary lesions and their peritoneal cavity metastases in treatment-naïve patients: A single-center study. Cancer Med 2022. [PMID: 35212471 DOI: 10.1002/cam4.4600] [Reference Citation Analysis]
10 Martin-Fernandez ML. Fluorescence Imaging of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Resistance in Non-Small Cell Lung Cancer. Cancers (Basel) 2022;14:686. [PMID: 35158954 DOI: 10.3390/cancers14030686] [Reference Citation Analysis]
11 Lu Y, Sandoval A, Voss S, Lai Z, Kneitz S, Boswell W, Boswell M, Savage M, Walter C, Warren W, Schartl M, Walter R. Oncogenic allelic interaction in Xiphophorus highlights hybrid incompatibility. Proc Natl Acad Sci U S A 2020;117:29786-94. [PMID: 33168740 DOI: 10.1073/pnas.2010133117] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
12 Getz M, Rangamani P, Ghosh P. Regulating cellular cyclic adenosine monophosphate: "Sources," "sinks," and now, "tunable valves". Wiley Interdiscip Rev Syst Biol Med 2020;12:e1490. [PMID: 32323924 DOI: 10.1002/wsbm.1490] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Subramaniyan V, Fuloria S, Gupta G, Kumar DH, Sekar M, Sathasivam KV, Sudhakar K, Alharbi KS, Al-Malki WH, Afzal O, Kazmi I, Al-Abbasi FA, Altamimi ASA, Fuloria NK. A review on epidermal growth factor receptor's role in breast and non-small cell lung cancer. Chem Biol Interact 2021;351:109735. [PMID: 34742684 DOI: 10.1016/j.cbi.2021.109735] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
14 Kechin A, Borobova V, Kel A, Ivanov A, Filipenko M. ErbB4 Is a Potential Key Regulator of the Pathways Activated by NTRK-Fusions in Thyroid Cancer. Applied Sciences 2022;12:2506. [DOI: 10.3390/app12052506] [Reference Citation Analysis]
15 Xiao D, Huang Y, Huang S, Zhuang J, Chen P, Wang Y, Zhang L. Targeted delivery of cancer drug paclitaxel to chordomas tumor cells via an RNA nanoparticle harboring an EGFR aptamer. Colloids Surf B Biointerfaces 2022;212:112366. [PMID: 35144131 DOI: 10.1016/j.colsurfb.2022.112366] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Skóra B, Piechowiak T, Szychowski KA. Epidermal growth factor-labeled liposomes as a way to target the toxicity of silver nanoparticles into EGFR-overexpressing cancer cells in vitro. Toxicology and Applied Pharmacology 2022. [DOI: 10.1016/j.taap.2022.116009] [Reference Citation Analysis]
17 Bennani FE, Doudach L, Karrouchi K, Tarib A, Rudd CE, Ansar M, Faouzi MEA. Targeting EGFR, RSK1, RAF1, PARP2 and LIN28B for several cancer type therapies with newly synthesized pyrazole derivatives via a computational study. J Biomol Struct Dyn 2022;:1-25. [PMID: 35442150 DOI: 10.1080/07391102.2022.2064915] [Reference Citation Analysis]
18 Pathak A, Pandey V, Raj Pokharel Y, Devaraji V, Ali A, Haider K, Saad S, Dewangan RP, Siddiqui N, Shahar Yar M. Pharmacophore based drug design and synthesis of oxindole bearing hybrid as anticancer agents. Bioorg Chem 2021;116:105358. [PMID: 34544029 DOI: 10.1016/j.bioorg.2021.105358] [Reference Citation Analysis]
19 Gbetuwa M, Lu L, Wang T, Chen Y, Chiou J, Su T, Yang T. Nucleus Near-Infrared (nNIR) Irradiation of Single A549 Cells Induces DNA Damage and Activates EGFR Leading to Mitochondrial Fission. Cells 2022;11:624. [DOI: 10.3390/cells11040624] [Reference Citation Analysis]
20 Pham QT, Taniyama D, Sekino Y, Akabane S, Babasaki T, Kobayashi G, Sakamoto N, Sentani K, Oue N, Yasui W. Clinicopathologic features of TDO2 overexpression in renal cell carcinoma. BMC Cancer 2021;21:737. [PMID: 34174844 DOI: 10.1186/s12885-021-08477-1] [Reference Citation Analysis]
21 Karlsen EA, Kahler S, Tefay J, Joseph SR, Simpson F. Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review. Cells 2021;10:1206. [PMID: 34069119 DOI: 10.3390/cells10051206] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
22 Arjmand B, Hamidpour SK, Tayanloo-beik A, Goodarzi P, Aghayan HR, Adibi H, Larijani B. Machine Learning: A New Prospect in Multi-Omics Data Analysis of Cancer. Front Genet 2022;13:824451. [DOI: 10.3389/fgene.2022.824451] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
23 Anbuselvam M, Easwaran M, Meyyazhagan A, Anbuselvam J, Bhotla HK, Sivasubramanian M, Annadurai Y, Kaul T, Pappusamy M, Balasubramanian B. Structure-based virtual screening, pharmacokinetic prediction, molecular dynamics studies for the identification of novel EGFR inhibitors in breast cancer. J Biomol Struct Dyn 2021;39:4462-71. [PMID: 32567493 DOI: 10.1080/07391102.2020.1777899] [Reference Citation Analysis]
24 Chen Y, Zhang Z, Henson ES, Cuddihy A, Haigh K, Wang R, Haigh JJ, Gibson SB. Autophagy inhibition by TSSC4 (tumor suppressing subtransferable candidate 4) contributes to sustainable cancer cell growth. Autophagy 2021;:1-23. [PMID: 34530675 DOI: 10.1080/15548627.2021.1973338] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Westphal D, Garzarolli M, Sergon M, Horak P, Hutter B, Becker JC, Wiegel M, Maczey E, Blum S, Grosche-Schlee S, Rütten A, Ugurel S, Stenzinger A, Glimm H, Aust D, Baretton G, Beissert S, Fröhling S, Redler S, Surowy H, Meier F. High tumour mutational burden and EGFR/MAPK pathway activation are therapeutic targets in metastatic porocarcinoma. Br J Dermatol 2021. [PMID: 34185311 DOI: 10.1111/bjd.20604] [Reference Citation Analysis]
26 Kaufman NEM, Dhingra S, Jois SD, Vicente MDGH. Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR). Molecules 2021;26:1076. [PMID: 33670650 DOI: 10.3390/molecules26041076] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
27 Butkiewicz D, Krześniak M, Gdowicz-Kłosok A, Giglok M, Marszałek-Zeńczak M, Suwiński R. Polymorphisms in EGFR Gene Predict Clinical Outcome in Unresectable Non-Small Cell Lung Cancer Treated with Radiotherapy and Platinum-Based Chemoradiotherapy. Int J Mol Sci 2021;22:5605. [PMID: 34070597 DOI: 10.3390/ijms22115605] [Reference Citation Analysis]
28 Fuentes NR, Mlih M, Wang X, Webster G, Cortes-Acosta S, Salinas ML, Corbin IR, Karpac J, Chapkin RS. Membrane therapy using DHA suppresses epidermal growth factor receptor signaling by disrupting nanocluster formation. J Lipid Res 2021;62:100026. [PMID: 33515553 DOI: 10.1016/j.jlr.2021.100026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Lin SR, Wen YC, Yeh HL, Jiang KC, Chen WH, Mokgautsi N, Huang J, Chen WY, Liu YN. EGFR-upregulated LIFR promotes SUCLG2-dependent castration resistance and neuroendocrine differentiation of prostate cancer. Oncogene 2020;39:6757-75. [PMID: 32963351 DOI: 10.1038/s41388-020-01468-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
30 Gonçalves ECD, Baldasso GM, Bicca MA, Paes RS, Capasso R, Dutra RC. Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant. Molecules 2020;25:E1567. [PMID: 32235333 DOI: 10.3390/molecules25071567] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
31 Barcus CE, Hwang PY, Morikis V, Brenot A, Pence P, Clarke M, Longmore GD. Tyrosine kinase-independent actions of DDR2 in tumor cells and cancer-associated fibroblasts influence tumor invasion, migration and metastasis. J Cell Sci 2021;134:jcs258431. [PMID: 34477203 DOI: 10.1242/jcs.258431] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 Li K, Zhang TT, Zhao CX, Wang F, Cui B, Yang ZN, Lv XX, Yeerjiang Z, Yuan YF, Yu JM, Wang ZH, Zhang XW, Yu JJ, Liu SS, Shang S, Huang B, Hua F, Hu ZW. Faciogenital Dysplasia 5 supports cancer stem cell traits in basal-like breast cancer by enhancing EGFR stability. Sci Transl Med 2021;13:eabb2914. [PMID: 33762435 DOI: 10.1126/scitranslmed.abb2914] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Barnes P, Yeboah FA, Zhu J, Saahene RO, Obirikorang C, Adinortey MB, Amoani B, Kyei F, Akakpo P, Awuku YA. Prognostic Worth of Epidermal Growth Factor Receptor (EGFR) in Patients with Head and Neck Tumors. J Cancer Epidemiol 2020;2020:5615303. [PMID: 33273921 DOI: 10.1155/2020/5615303] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 Alessandrini L, Astolfi L, Franz L, Gentilin E, Mazzoni A, Zanoletti E, Marioni G. Temporal Bone Squamous Cell Carcinoma: Molecular Markers Involved in Carcinogenesis, Behavior, and Prognosis: A Systematic Review. Int J Mol Sci 2022;23:4536. [PMID: 35562926 DOI: 10.3390/ijms23094536] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Calibasi-Kocal G, Amirfallah A, Sever T, Umit Unal O, Gurel D, Oztop I, Ellidokuz H, Basbinar Y. EGFR mutation status in a series of Turkish non-small cell lung cancer patients. Biomed Rep 2020;13:2. [PMID: 32509305 DOI: 10.3892/br.2020.1308] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
36 Komatsu M, Nakamura K, Takeda T, Chiwaki F, Banno K, Aoki D, Takeshita F, Sasaki H. Aurora kinase blockade drives de novo addiction of cervical squamous cell carcinoma to druggable EGFR signalling. Oncogene. [DOI: 10.1038/s41388-022-02256-3] [Reference Citation Analysis]
37 Tseng YK, Chen CF, Shu CW, Lee CH, Chou YT, Li YJ, Liou HH, Cheng JT, Chen CL, Ger LP, Liu PF. Effect of EGFR on SQSTM1 Expression in Malignancy and Tumor Progression of Oral Squamous Cell Carcinoma. Int J Mol Sci 2021;22:12226. [PMID: 34830108 DOI: 10.3390/ijms222212226] [Reference Citation Analysis]
38 Hassan Nazmy M, Ahmed Mekheimer R, Shoman ME, Abo-Elsebaa M, Abd-Elmonem M, Usef Sadek K. Controlled microwave-assisted reactions: A facile synthesis of polyfunctionally substituted phthalazines as dual EGFR and PI3K inhibitors in CNS SNB-75 cell line. Bioorg Chem 2022;122:105740. [PMID: 35298961 DOI: 10.1016/j.bioorg.2022.105740] [Reference Citation Analysis]
39 Yao N, Wang CR, Liu MQ, Li YJ, Chen WM, Li ZQ, Qi Q, Lu JJ, Fan CL, Chen MF, Qi M, Li XB, Hong J, Zhang DM, Ye WC. Discovery of a novel EGFR ligand DPBA that degrades EGFR and suppresses EGFR-positive NSCLC growth. Signal Transduct Target Ther 2020;5:214. [PMID: 33033232 DOI: 10.1038/s41392-020-00251-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
40 Lin CW, Nocka LM, Stinger BL, DeGrandchamp JB, Lew LJN, Alvarez S, Phan HT, Kondo Y, Kuriyan J, Groves JT. A two-component protein condensate of the EGFR cytoplasmic tail and Grb2 regulates Ras activation by SOS at the membrane. Proc Natl Acad Sci U S A 2022;119:e2122531119. [PMID: 35507881 DOI: 10.1073/pnas.2122531119] [Reference Citation Analysis]
41 Hameduh T, Mokry M, Miller AD, Adam V, Heger Z, Haddad Y. A rotamer relay information system in the epidermal growth factor receptor-drug complexes reveals clues to new paradigm in protein conformational change. Comput Struct Biotechnol J 2021;19:5443-54. [PMID: 34667537 DOI: 10.1016/j.csbj.2021.09.026] [Reference Citation Analysis]
42 Nag A, Das S. Fluorescent Sensors of Phosphate Containing Biomolecules. Isr J Chem 2021;61:169-84. [DOI: 10.1002/ijch.202000087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Meena DS, Kumar D, Bohra GK, Midha N. Gefitinib induced severe hyponatremia: A case report. J Oncol Pharm Pract 2021;27:711-5. [PMID: 32686614 DOI: 10.1177/1078155220942302] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Khalid AQ, Bhuvanendran S, Magalingam KB, Ramdas P, Kumari M, Radhakrishnan AK. Clinically Relevant Genes and Proteins Modulated by Tocotrienols in Human Colon Cancer Cell Lines: Systematic Scoping Review. Nutrients 2021;13:4056. [PMID: 34836311 DOI: 10.3390/nu13114056] [Reference Citation Analysis]
45 Mensa-Wilmot K. How Physiologic Targets Can Be Distinguished from Drug-Binding Proteins. Mol Pharmacol 2021;100:1-6. [PMID: 33941662 DOI: 10.1124/molpharm.120.000186] [Reference Citation Analysis]
46 Andreu I, Lence E, González-Bello C, Mayorga C, Cuquerella MC, Vayá I, Miranda MA. Protein Binding of Lapatinib and Its N- and O-Dealkylated Metabolites Interrogated by Fluorescence, Ultrafast Spectroscopy and Molecular Dynamics Simulations. Front Pharmacol 2020;11:576495. [PMID: 33192518 DOI: 10.3389/fphar.2020.576495] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
47 Oprita A, Baloi SC, Staicu GA, Alexandru O, Tache DE, Danoiu S, Micu ES, Sevastre AS. Updated Insights on EGFR Signaling Pathways in Glioma. Int J Mol Sci 2021;22:E587. [PMID: 33435537 DOI: 10.3390/ijms22020587] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
48 Taber S, Pfannschmidt J. Validation of the 8th lung cancer TNM classification and clinical staging system in a German cohort of surgically resected patients. Innov Surg Sci 2020;5:1-9. [PMID: 33506088 DOI: 10.1515/iss-2020-0010] [Reference Citation Analysis]